Loading…
Park Ha Biological Technology Co., Ltd. is projected to decline to $0.5742 by 2027, a -1% move from its current price of $0.58. BYAH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.5172 | $0.58 | $0.6506 | +0.01% |
| Jul 15 | $0.4932 | $0.5801 | $0.6823 | +0.02% |
| Jul 16 | $0.4756 | $0.5801 | $0.7077 | +0.02% |
| Jul 17 | $0.4612 | $0.5802 | $0.7298 | +0.03% |
| Jul 18 | $0.4489 | $0.5802 | $0.7499 | +0.04% |
| Jul 19 | $0.4381 | $0.5803 | $0.7685 | +0.05% |
| Jul 20 | $0.4284 | $0.5803 | $0.7861 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4284 | $0.5803 | $0.7861 | +0.05% |
| Week 2 | $0.378 | $0.5806 | $0.8919 | +0.11% |
| Week 3 | $0.3434 | $0.5809 | $0.9827 | +0.16% |
| Week 4 | $0.3167 | $0.5812 | $1.07 | +0.21% |
| Week 5 | $0.295 | $0.5815 | $1.15 | +0.26% |
| Week 6 | $0.2766 | $0.5818 | $1.22 | +0.32% |
| Week 7 | $0.2608 | $0.5821 | $1.30 | +0.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Park Ha Biological Technology Co., Ltd. is an investment holding company that develops skincare products in the People's Republic of China. It operates in two segments, Product Sales and Franchise Service.
The company offers products such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company has strategic partnerships with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach, and with Cloud Factory Technology Holdings Limited to build an ai-driven ecosystem for the beauty industry.
The company was founded in 2016 and is headquartered in Wuxi, the People’s Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
BYAH is the stock ticker for Park Ha Biological Technology Co., Ltd. The current price is $0.58 and the market capitalization is $3.66M, with a rank of 5344. The asset sits in the Consumer Defensive category.
A major floor 0.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 356.9% above — a clean break opens room to run.
A major ceiling 475.9% above — clearing it would confirm fresh momentum.
Key BYAH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BYAH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6872 | Sell | $0.7007 | Sell |
| MA 10 | $0.8524 | Sell | $0.8317 | Sell |
| MA 20 | $1.09 | Sell | $0.9933 | Sell |
| MA 50 | $1.19 | Sell | $1.30 | Sell |
| MA 100 | $1.27 | Sell | $7.83 | Sell |
| MA 200 | $7.17 | Sell | $53.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.26 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -133.61 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -57.97 | Sell |
| Bollinger %B (20,2) | 0.06 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.12 | Sell |
| Awesome (5,34) | -0.49 | Sell |
| Ultimate (7,14,28) | 13.82 | Buy |
| Momentum (10) | -0.64 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 0.60 | Sell |
| ADX (14) | 14.90 | Neutral |
| ATR (14) | 0.12 | Info |
The near-term technical picture shows Bearish sentiment. The RSI(14) is 40, and the 50-day simple moving average (SMA) is $1.19 while the 200-day SMA is $7.17. The stock trades with a defined support at $0.58 and a resistance at $2.65.
Over the last 30 days, the price range has been from a low of $0.2723 to a high of $1.24. Annualized volatility is 200, indicating a high level of price fluctuation.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $0.58 | $0.699 | 0% | Neutral | |
| $0.4166 | $0.5742 | $0.8557 | -1% | Neutral | |
| $0.4892 | $0.7165 | $1.14 | +24% | Bullish | |
| $0.5577 | $0.8605 | $1.43 | +48% | Bullish | |
| $0.4633 | $0.7494 | $1.30 | +29% | Bullish | |
| $0.3917 | $0.6621 | $1.19 | +14% | Neutral | |
| $0.4242 | $0.748 | $1.39 | +29% | Bullish | |
| $0.3366 | $0.6181 | $1.18 | +7% | Neutral | |
| $0.4093 | $0.7818 | $1.53 | +35% | Bullish | |
| $0.5505 | $1.09 | $2.18 | +88% | Bullish | |
| $0.4977 | $1.11 | $2.43 | +91% | Bullish | |
| $0.7853 | $1.75 | $4.01 | +201% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.58 | $0.58 | $0.7183 | +0.00% |
| August 2026 | $0.5097 | $0.6174 | $0.7787 | +6.44% |
| September 2026 | $0.4754 | $0.584 | $0.7521 | -5.41% |
| October 2026 | $0.417 | $0.5185 | $0.6795 | -11.21% |
| November 2026 | $0.4092 | $0.5142 | $0.6836 | -0.83% |
| December 2026 | $0.4089 | $0.5189 | $0.699 | +0.91% |
Click any year to see its month-by-month BYAH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BYAH price prediction for 2026 points to an average of $0.58 (low $0.58, high $0.699) — a potential gain of 0% on today's $0.58. A consolidation phase looks the most probable path here.
In 2027, BYAH is projected to trade between $0.4166 and $0.8557, averaging $0.5742 — a potential decline of -1% from today's $0.58. That is -1% versus the projected 2026 average. Price action looks broadly range-bound.
Park Ha Biological Technology Co., Ltd.'s 2028 outlook centres on $0.7165, within a $0.4892 to $1.14 range. That is up +25% on the projected 2027 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BYAH could reach as high as $1.43, with a base case around $0.8605 and support toward $0.5577 — roughly +48% from $0.58. Momentum favours further upside here.
Expect BYAH to range from $0.4633 to $1.30 through 2030. The $0.7494 average target implies a +29% move from current prices. That is -13% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The BYAH price prediction for 2031 points to an average of $0.6621 (low $0.3917, high $1.19) — a potential gain of +14% on today's $0.58. Price action looks broadly range-bound.
In 2032, BYAH is projected to trade between $0.4242 and $1.39, averaging $0.748 — a potential gain of +29% from today's $0.58. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Park Ha Biological Technology Co., Ltd.'s 2033 outlook centres on $0.6181, within a $0.3366 to $1.18 range. That is -17% versus the projected 2032 average. That marks a +7% change versus current levels. Price action looks broadly range-bound.
By 2034, BYAH could reach as high as $1.53, with a base case around $0.7818 and support toward $0.4093 — roughly +35% from $0.58. Buyers look set to stay in control over this stretch.
Expect BYAH to range from $0.5505 to $2.18 through 2035. The $1.09 average target implies a +88% move from current prices. That is up +40% on the projected 2034 average. Momentum favours further upside here.
The BYAH price prediction for 2040 points to an average of $1.11 (low $0.4977, high $2.43) — a potential gain of +91% on today's $0.58. Buyers look set to stay in control over this stretch.
In 2050, BYAH is projected to trade between $0.7853 and $4.01, averaging $1.75 — a potential gain of +201% from today's $0.58. That is up +58% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BYAH today (≈ 1,724.137931 BYAH) could be worth
$3,008.93
+$2,008.93 (+201%) by 2050 · US Dollar
Based on the average projected BYAH price of $1.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BYAHwould be worth at today's price.
$1,000 invested in BYAH on Jul 10, 2025 (≈ 17.391304 BYAH) would be worth
$10.09
-$989.91 (-99.0%) today · 0.01× · US Dollar
Based on a BYAH entry price of $57.5 vs. today's $0.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.837 | $692.95 | -30.7% |
| 1 month ago | $1.24 | $467.74 | -53.2% |
| 3 months ago | $1.04 | $557.69 | -44.2% |
| 6 months ago | $8.05 | $72.05 | -92.8% |
| 1 year ago | $57.5 | $10.09 | -99.0% |
| All time (1.5y) ago | $203.5 | $2.85 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BYAH forecast.
Our base-case forecast reaches $1.20 around 2050.
Implied market cap at $1.20: $7.12M
The multi-year forecast depicts a path of upside potential with varying momentum. In 2028 the avg is $0.7187 (min $0.4906, max $1.14) and in 2029 the avg is $0.8592 (min $0.5568, max $1.43), with bullish sentiment. By 2030 the avg is $0.7484 and the ROI is 29%, continuing a bullish trend.
The trajectory strengthens toward 2040 with an avg of $1.11 and ROI of 91.3%, and reaches 2050 with an avg of $1.74 and ROI of 200.3%. Key longer-horizon milestones include 2030 (avg $0.7484, ROI 29, bullish), 2040 (avg $1.11, ROI 91.3, bullish), and 2050 (avg $1.74, ROI 200.3, bullish). There are some neutral years along the way (e.g., 2026, 2027, 2031, 2033), reflecting a mixed pace of growth.
Overall, the forecast points to meaningful long-term upside, but it is not a guarantee and is subject to market and business risks.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $0.7484 with a min of $0.4626 and a max of $1.30, and a forecasted ROI of 29%. The sentiment is bullish.
The forecast includes years with bullish sentiment (e.g., 2028, 2029, 2040, 2050) and a long-term upside with an avg of $1.74 by 2050 and ROI of 200.3%. There are also neutral years and some variability, so outcomes are not guaranteed.
According to the forecast, BYAH’s 2050 max is $4.01, which exceeds $2.65, indicating potential to surpass that level on the long horizon. Earlier years show lower max values (e.g., 2035 max $2.18, 2040 max $2.44).
The current price is $0.58 and the market capitalization is $3.66M. The stock ranks 5344 by market cap.
Support is at $0.58 and resistance at $2.65. The RSI(14) is 40, the SMA50 is $1.19, and the SMA200 is $7.17. The 30-day range is from $0.2723 to $1.24, and annualized volatility is 200.
Park Ha Biological Technology Co., Ltd. Community Discussion
0Share your Park Ha Biological Technology Co., Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.